Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $40

Benzinga · 1d ago
Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $39 to $40.